Community-acquired pneumonia (CAP) is a significant cause of morbidity and mortality worldwide. Cephalosporin drugs play a crucial role in the treatment of CAP due to their potent activity against common respiratory pathogens. They are often recommended as first-line therapy, especially in moderate to severe cases. Cephalosporins such as ceftriaxone, cefotaxime, and cefpodoxime demonstrate...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian